UC Davis School of Medicine continues its leadership in medical research with 10 departments ranked in the top 20, including three in the top 10, for research funding from the National Institutes of Health (NIH) in 2018.
The rankings, published each year in early February, place UC Davis among the nation’s leading medical schools for NIH funding, a recognized measure of research excellence. The rankings are compiled by Blue Ridge Institute for Medical Research, a nonprofit organization that uses the NIH’s Research Portfolio Online Reporting Tool for its annual reports.
UC Davis School of Medicine departments in Top 20 for NIH funding
|Public Health, 7th||Microbiology/immunology, 15th|
|Emergency Medicine, 7th||Psychiatry, 15th|
|Dermatology, 10th||Biochemistry, 16th|
|Surgery, 11th||Neurology, 16th|
|Anatomy/Cell Biology, 12th||Pharmacology, 18th|
In 2018, the School of Medicine’s NIH funding topped $178 million, with 41 principal investigators receiving grants over a $1 million and three over $5 million. The funding supports many innovative projects, including Explorer, the world’s first total-body 3D scanner, as well as studies that aim to shed light on chemical and nonchemical stressors that may impact ADHD, mood disorders, cognitive performance and other outcomes in children.
For the last five years, the School of Medicine sustained its growth trajectory in NIH-funded grants for medical research, maintaining its ranking among the Top 30 U.S. NIH-funded institutions in 2018.
NIH funding supports leading-edge research that saves lives, improves health
According to Lars Berglund, interim dean of the School of Medicine and vice dean of research, NIH funding enables leading-edge research to develop into discoveries that save lives and improve health.
“The rankings reflect the strong spirit of collaboration and pursuit of innovation and excellence of our diverse research community,” he said. “I am proud of their outstanding dedication and efforts, which are focused on understanding the underlying mechanisms of disease, developing new treatments and technologies, and addressing some of our nation’s most challenging issues in health and health care.”